Carna Biosciences, Inc.

4572・Growth Market・Pharmaceuticals

Official website

Carna Biosciences, Inc.

4572・Growth Market・Pharmaceuticals

Official website

Carna Biosciences, Inc.4572

Reference Indicators

Market Cap

65¥100M

P/E (Forecast)

—

P/B

20.9x

Dividend Yield (Forecast)

0.00%

ROE

-941.4%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	2,017	1,386	1,625	636	579
Cost of Sales	135	171	175	170	190
Gross Profit	1,882	1,215	1,450	465	388
SG&A Expenses	2,413	2,485	2,567	2,541	2,463
Operating Income	-531	-1,269	-1,116	-2,076	-2,074
Non-operating Income	24	5	0	44	5
Non-operating Expenses	16	14	10	48	75
Ordinary Income	-522	-1,278	-1,126	-2,080	-2,144
Extraordinary Losses	9	44	4	93	24
Pre-tax Income	-532	-1,323	-1,130	-2,173	-2,169
Income Taxes	1	26	22	4	1
Net Income	-534	-1,349	-1,152	-2,178	-2,171
EBITDA	-511	-1,236	-1,081	-2,044	—
Gross Margin	93.3%	87.6%	89.2%	73.2%	67.0%
Operating Margin	-26.3%	-91.6%	-68.7%	-326.3%	-358.3%
ROA	-9.8%	-31.6%	-26.5%	-78.6%	-176.6%
ROE	-12.5%	-34.0%	-30.1%	-91.1%	-941.4%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
創薬支援事業	579	-50	-8.6%
創薬事業	0	-2,024	0.0%
その他	0	0	0.0%